Related Experiment Video
Updated: Apr 15, 2026
Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
Published on: December 11, 2019
AI-Enabled Sensor Technologies for Remote Arrhythmic Monitoring in High-Risk Cardiomyopathy Genotypes
Nardi Tetaj1,2, Andrea Segreti1,2, Francesco Piccirillo1,2
1Cardiology Unit, Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
Insights
Artificial intelligence (AI) sensor technology offers remote arrhythmic monitoring for inherited cardiomyopathies. This approach promises proactive prevention of sudden cardiac death by analyzing continuous data, but requires genotype-specific validation.
Area of Science:
- Cardiology
- Biomedical Engineering
- Artificial Intelligence
Background:
- Inherited cardiomyopathies carry high risk for malignant ventricular arrhythmias and sudden cardiac death, often unrelated to traditional markers.
- Current surveillance methods are inadequate for detecting silent electrical instability in these high-risk patients.
- Genotype-specific risk stratification is crucial for understanding disease progression.
Purpose of the Study:
- To review the role of artificial intelligence (AI)-enabled sensor technologies in remote arrhythmic monitoring for inherited cardiomyopathy patients.
- To evaluate the potential of continuous electrophysiological and hemodynamic data acquisition for early detection of arrhythmic vulnerability.
- To identify challenges and future directions for implementing AI-driven sensing in genotype-specific cohorts.
Main Methods:
- Narrative review of emerging AI-enabled sensor technologies, including wearable ECGs, implantable monitors, and multisensor devices.
- Analysis of how AI enhances signal processing, automated event detection, and remote data triage.
- Examination of digital biomarkers derived from continuous data streams for early detection of arrhythmias and decompensation.
Main Results:
- AI-enabled sensors provide continuous electrophysiological and hemodynamic data, generating digital biomarkers for early arrhythmic risk.
- AI analytics can improve signal processing and automated event detection, potentially reducing clinical workload.
- Current evidence is limited, with most studies in general heart failure or arrhythmia populations, necessitating genotype-specific validation.
Conclusions:
- AI-enabled sensing combined with genotype information offers a promising shift towards proactive, precision-guided arrhythmic prevention in inherited cardiomyopathies.
- Further research, including genotype-focused studies and standardized digital endpoints, is essential for safe and effective clinical implementation.
- Addressing challenges like algorithm generalizability and data integration is key to realizing the full potential of these technologies.
Abstract:
Inherited cardiomyopathies associated with high-risk genotypes, are characterized by a disproportionate risk of malignant ventricular arrhythmias and sudden cardiac death, often independent of left ventricular systolic dysfunction or advanced structural remodeling. Traditional surveillance strategies based on intermittent electrocardiography and phenotype-driven risk assessment are insufficient to capture the dynamic and often silent progression of electrical instability in these populations. This narrative review evaluates the emerging role of artificial intelligence (AI)-enabled sensor technologies in remote arrhythmic monitoring of genetically defined cardiomyopathy cohorts. Wearable ECG devices, implantable cardiac monitors, multisensor cardiac implantable electronic device algorithms, pulmonary artery pressure sensors, and contact-free systems enable continuous acquisition of electrophysiological and hemodynamic data, generating digital biomarkers that may reflect early arrhythmic vulnerability and subclinical decompensation. AI-driven analytics enhance signal processing, automated event detection, and remote data triage, with the potential to reduce clinical workload while preserving diagnostic sensitivity. However, current evidence predominantly derives from heterogeneous heart failure or general arrhythmia populations, and prospective validation in genotype-specific cohorts remains limited. Key challenges include algorithm generalizability, signal quality in ambulatory environments, data governance, interpretability of AI models, and integration into structured remote-care pathways. The convergence of genotype-informed risk stratification and multimodal AI-enabled sensing represents a promising strategy to transition from reactive device-based protection to proactive, precision-guided arrhythmic prevention. Dedicated genotype-focused studies and standardized digital endpoints are required to support safe and effective implementation in inherited cardiomyopathies.
More Related Videos
Related Concept Videos
01:30Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
01:23Holter Monitor: 24-Hour Monitoring
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:28Mechanism of Cardiac Arrhythmias
01:29Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy